| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ALKSAlkermes plc | 4.98B | 30.10 | 21.05 | -5.25% | 16.37% | 13.28% | 0.01% | 0.04 |
| ADMAADMA Biologics, Inc. | 3.71B | 15.57 | 19.22 | 65.15% | 42.87% | 48.57% | 2.97% | 0.24 |
| UTHRUnited Therapeutics Corporation | 21.99B | 503.90 | 18.09 | 10.61% | 41.94% | 18.81% | 4.73% | |
| PCSAProcessa Pharmaceuticals, Inc. | 114.71M | 2.17 | -0.56 | -221.71% | 0.04 | |||
| UNCYUnicycive Therapeutics, Inc. | 144.49M | 6.93 | -1.24 | -100% | -89.15% | 0.10 | ||
| PTHSPelthos Therapeutics Inc. | 85.29M | 26.36 | -1.95 | -318.41% | -40.48% | |||
| MISTMilestone Pharmaceuticals Inc. | 145.64M | 1.71 | -2.55 | -100% | -282.97% | 4.17 | ||
| AMRNAmarin Corporation plc | 5.74B | 13.80 | -3.45 | -25.51% | -38.01% | -18.78% | 0.02 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 951K | 675K | 0 |
| Revenue Growth % | - | - | - | - | - | -29.02% | -100% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 951K | 675K | 0 |
| Gross Margin % | - | - | - | - | 100% | 100% | - |
| Gross Profit Growth % | - | - | - | - | - | -29.02% | -100% |
| Operating Expenses | 952K | 1.96M | 2.02M | 8.98M | 19M | 21.45M | 32.12M |
| OpEx % of Revenue | - | - | - | - | 1998.21% | 3177.63% | - |
| Selling, General & Admin | 608K | 1.17M | 1M | 2.9M | 6.57M | 8.55M | 12.1M |
| SG&A % of Revenue | - | - | - | - | 690.54% | 1266.22% | - |
| Research & Development | 344K | 795K | 1.01M | 6.08M | 12.44M | 12.9M | 20.01M |
| R&D % of Revenue | - | - | - | - | 1307.68% | 1911.41% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -952K | -1.96M | -2.02M | -8.98M | -18.05M | -20.77M | -32.12M |
| Operating Margin % | - | - | - | - | -1898.21% | -3077.63% | - |
| Operating Income Growth % | - | -106.2% | -2.9% | -344.41% | -101.09% | -15.08% | -54.6% |
| EBITDA | 0 | 0 | 0 | -8.96M | -17.89M | -20.49M | -31.69M |
| EBITDA Margin % | - | - | - | - | -1881.28% | -3035.56% | - |
| EBITDA Growth % | - | - | - | - | -99.59% | -14.53% | -54.66% |
| D&A (Non-Cash Add-back) | 952K | 1.96M | 2.02M | 13K | 161K | 284K | 428K |
| EBIT | -952K | -2.03M | -2.02M | -9.39M | -18.05M | -30.46M | -36.66M |
| Net Interest Income | 0 | 0 | 0 | -628K | -6K | 533K | 1.19M |
| Interest Income | 168K | 139K | 244K | 0 | 0 | 615K | 1.26M |
| Interest Expense | 0 | 139K | 244K | 628K | 6K | 82K | 71K |
| Other Income/Expense | -168K | -202K | -244K | -1.04M | -6K | -9.77M | -4.61M |
| Pretax Income | -1.12M | -2.17M | -2.26M | -10.02M | -18.06M | -30.54M | -36.73M |
| Pretax Margin % | - | - | - | - | -1898.84% | -4525.04% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 100% | 106.42% | 110.78% | 100% | 100% | 100% | 100% |
| Net Income | -1.12M | -2.3M | -2.51M | -10.02M | -18.06M | -30.54M | -36.73M |
| Net Margin % | - | - | - | - | -1898.84% | -4525.04% | - |
| Net Income Growth % | - | -105.71% | -8.85% | -299.4% | -80.27% | -69.14% | -20.25% |
| Net Income (Continuing) | -1.12M | -2.17M | -2.26M | -10.02M | -18.06M | -30.54M | -36.73M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.14 | -0.27 | -0.16 | -8.60 | -1.20 | -1.28 | -5.60 |
| EPS Growth % | - | -92.86% | 40.74% | -5275% | 86.05% | -6.67% | -337.5% |
| EPS (Basic) | -0.14 | -0.27 | -0.16 | -8.60 | -1.20 | -1.28 | -5.60 |
| Diluted Shares Outstanding | 794.32K | 847.15K | 1.52M | 1.17M | 1.51M | 2.45M | 6.7M |
| Basic Shares Outstanding | 794.32K | 842.5K | 1.52M | 1.17M | 1.51M | 2.45M | 6.7M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 29K | 19K | 204K | 18.41M | 2.64M | 13.4M | 30.95M |
| Cash & Short-Term Investments | 25K | 15K | 0 | 16.58M | 455K | 9.7M | 26.14M |
| Cash Only | 25K | 15K | 0 | 16.58M | 455K | 9.7M | 26.14M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 4K | 204K | 126K | 159K | 325K | 939K |
| Total Non-Current Assets | 0 | 0 | 200K | 333K | 174K | 792K | 720K |
| Property, Plant & Equipment | 0 | 0 | 0 | 333K | 174K | 792K | 720K |
| Fixed Asset Turnover | - | - | - | - | 5.47x | 0.85x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 200K | 0 | 0 | 0 | 0 |
| Total Assets | 29K | 19K | 204K | 18.74M | 2.82M | 14.19M | 31.67M |
| Asset Turnover | - | - | - | - | 0.34x | 0.05x | - |
| Asset Growth % | - | -34.48% | 973.68% | 9088.24% | -84.97% | 403.58% | 123.16% |
| Total Current Liabilities | 1.24M | 903K | 2.88M | 2.1M | 3.28M | 17.53M | 24.12M |
| Accounts Payable | 60K | 322K | 184K | 742K | 846K | 821K | 966K |
| Days Payables Outstanding | - | - | - | - | - | - | - |
| Short-Term Debt | 1.05M | 460K | 2.51M | 29K | 46K | 18K | 92K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | -29K | 0 | 13.13M | 18.94M |
| Current Ratio | 0.02x | 0.02x | 0.07x | 8.75x | 0.81x | 0.76x | 1.28x |
| Quick Ratio | 0.02x | 0.02x | 0.07x | 8.75x | 0.81x | 0.76x | 1.28x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 155K | 0 | 466K | 117K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 155K | 0 | 466K | 117K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.24M | 903K | 2.88M | 2.26M | 3.28M | 18M | 24.24M |
| Total Debt | 1.05M | 460K | 2.51M | 335K | 201K | 811K | 773K |
| Net Debt | 1.02M | 445K | 2.51M | -16.24M | -254K | -8.89M | -25.37M |
| Debt / Equity | - | - | - | 0.02x | - | - | 0.10x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | -14.12x | -8.28x | -14.29x | -3008.67x | -253.34x | -452.35x |
| Total Equity | -1.21M | -884K | -2.67M | 16.48M | -466K | -3.81M | 7.43M |
| Equity Growth % | - | 26.7% | -202.15% | 717.15% | -102.83% | -717.38% | 295.09% |
| Book Value per Share | -1.52 | -1.04 | -1.75 | 14.12 | -0.31 | -1.55 | 1.11 |
| Total Shareholders' Equity | -1.21M | -884K | -2.67M | 16.48M | -466K | -3.81M | 7.43M |
| Common Stock | 34K | 8K | 9K | 15K | 15K | 35K | 114K |
| Retained Earnings | -1.49M | -3.66M | -5.92M | -15.94M | -34M | -64.54M | -101.27M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -775K | -1.18M | -1.46M | -5.77M | -15.65M | -18.28M | -28.57M |
| Operating CF Margin % | - | - | - | - | -1645.74% | -2708.59% | - |
| Operating CF Growth % | - | -51.74% | -24.06% | -295.27% | -171.39% | -16.82% | -56.29% |
| Net Income | -1.12M | -2.17M | -2.26M | -10.02M | -18.06M | -30.54M | -36.73M |
| Depreciation & Amortization | 0 | 0 | 0 | 13K | 161K | 284K | 428K |
| Stock-Based Compensation | 0 | 24K | 232K | 966K | 1.05M | 1.77M | 2.35M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 308K | 660K | 739K | 3.38M | 21K | 10.3M | 5.8M |
| Working Capital Changes | 6K | 305K | -166K | -105K | 1.18M | -93K | -427K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 31K | 308K | -68K | 1.24M | 1.27M | 1.28M | 790K |
| Cash from Investing | 0 | 0 | 0 | -29K | -2K | -12K | -72K |
| Capital Expenditures | 0 | 0 | 0 | -29K | -2K | -12K | -72K |
| CapEx % of Revenue | - | - | - | - | 0.21% | 1.78% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 800K | 1.17M | 1.44M | 22.38M | -471K | 27.54M | 45.09M |
| Debt Issued (Net) | 0 | 0 | 1.42M | -15K | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 1000K | 141K | 1000K | 11K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | -1.09M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 800K | 0 | -117K | 119K | -482K | -2.65M | -4.5M |
| Net Change in Cash | 25K | -10K | -15K | 16.58M | -16.12M | 9.25M | 16.44M |
| Free Cash Flow | -775K | -1.18M | -1.46M | -5.8M | -15.65M | -18.3M | -28.65M |
| FCF Margin % | - | - | - | - | -1645.95% | -2710.37% | - |
| FCF Growth % | - | -51.74% | -24.06% | -297.26% | -170.07% | -16.88% | -56.58% |
| FCF per Share | -0.98 | -1.39 | -0.96 | -4.96 | -10.40 | -7.46 | -4.28 |
| FCF Conversion (FCF/Net Income) | 0.69x | 0.51x | 0.58x | 0.58x | 0.87x | 0.60x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 24K | 0 |
| Taxes Paid | 0 | 2K | 1K | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -145.04% | -225.47% | - | -2028.11% |
| Return on Invested Capital (ROIC) | - | - | - | -16223.49% | - | - | - |
| Gross Margin | - | - | - | - | 100% | 100% | - |
| Net Margin | - | - | - | - | -1898.84% | -4525.04% | - |
| Debt / Equity | - | - | - | 0.02x | - | - | 0.10x |
| Interest Coverage | - | -14.12x | -8.28x | -14.29x | -3008.67x | -253.34x | -452.35x |
| FCF Conversion | 0.69x | 0.51x | 0.58x | 0.58x | 0.87x | 0.60x | 0.78x |
| Revenue Growth | - | - | - | - | - | -29.02% | -100% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics